Not exact matches
Flu
vaccines work by introducing a killed version of circulating virus
strains, which trains the body's immune system to recognize and attack
similar invaders in the future.
GlaxoSmithKline has developed a
similar vaccine that protects against the two cancer - provoking
strains.
Many researchers at NIH, universities and medical schools are looking for antibodies that act on a broad range of flu
strains, with the goal of understanding how they attach to the viruses and then designing
vaccines or other flu therapies that produce a
similar effect.
It's the
vaccine developers» best guess as to whether or not the current infective organisms are the same
strain as the
vaccine, a process
similar to what happens the human flu
vaccines.